- Page 1: Escaping the Scalpel In-depth evide
- Page 4 and 5: Colofon Copyright © J.C.A. Noorduy
- Page 6 and 7: 4 promotoren: copromotoren: prof.dr
- Page 8 and 9: 6
- Page 11 and 12: Chapter 1 General introduction
- Page 13 and 14: GENERAL INTRODUCTION11 program. How
- Page 15 and 16: GENERAL INTRODUCTION13 potential be
- Page 17 and 18: GENERAL INTRODUCTION15 lect those p
- Page 19 and 20: GENERAL INTRODUCTION17 References I
- Page 21: GENERAL INTRODUCTION19 34. van de G
- Page 24 and 25: 22 CHAPTER II Abstract Background:
- Page 28 and 29: 26 CHAPTER II Outcome Measures Four
- Page 30 and 31: 28 CHAPTER II Table 2. Scores at Ba
- Page 32 and 33: 30 CHAPTER II Responsiveness Of 10
- Page 34 and 35: 32 CHAPTER II ness among 100 patien
- Page 36 and 37: 34 CHAPTER II References 1. Abram S
- Page 39 and 40: Chapter 3 Functional Outcomes of Ar
- Page 41 and 42: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 43 and 44: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 45 and 46: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 47 and 48: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 49 and 50: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 51 and 52: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 53 and 54: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 55 and 56: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 57: FUNCTIONAL SCORE OF APM VS PHYSICAL
- Page 60 and 61: 58 CHAPTER IV Abstract Background.
- Page 62 and 63: 60 CHAPTER IV Methods Two predictio
- Page 64 and 65: 62 CHAPTER IV of the calibration pl
- Page 66 and 67: 64 CHAPTER IV Multivariable regress
- Page 68 and 69: 66 CHAPTER IV Discussion Two progno
- Page 70 and 71: 68 CHAPTER IV References 1. Abram S
- Page 73 and 74: Chapter 5 An individualized decisio
- Page 75 and 76: MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 77 and 78:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 79 and 80:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 81 and 82:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 83 and 84:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 85 and 86:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 87 and 88:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 89 and 90:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 91:
MARKER-BY-TREATMENT ANALYSIS OF THE
- Page 94 and 95:
92 CHAPTER VI Abstract Importance T
- Page 96 and 97:
94 CHAPTER VI Introduction Randomiz
- Page 98 and 99:
96 CHAPTER VI Intervention Arthrosc
- Page 100 and 101:
98 CHAPTER VI score (range, 0 [best
- Page 102 and 103:
100 CHAPTER VI Results Patients We
- Page 104 and 105:
102 CHAPTER VI Table 1. Baseline ch
- Page 106 and 107:
104 CHAPTER VI Over the 5 years of
- Page 108 and 109:
106 CHAPTER VI Table 2. Crude and A
- Page 110 and 111:
108 CHAPTER VI Table 3. Five year o
- Page 112 and 113:
110 CHAPTER VI of exercise-based ph
- Page 114 and 115:
112 CHAPTER VI References 1. Gauffi
- Page 116 and 117:
114 CHAPTER VI 33. Pihl K, Ensor J,
- Page 119 and 120:
Chapter 7 General Discussion
- Page 121 and 122:
GENERAL DISCUSSION & CONCLUSION119
- Page 123 and 124:
GENERAL DISCUSSION & CONCLUSION121
- Page 125 and 126:
GENERAL DISCUSSION & CONCLUSION123
- Page 127:
GENERAL DISCUSSION & CONCLUSION125
- Page 130 and 131:
128 CHAPTER VIII What we already kn
- Page 132 and 133:
130 CHAPTER VIII analyses to reveal
- Page 134 and 135:
132 CHAPTER VIII References 1. Abra
- Page 136 and 137:
134 CHAPTER VIII basis van de activ
- Page 139 and 140:
Chapter 9 Appendices
- Page 141 and 142:
APPENDICES139 Appendix 1 Physical t
- Page 143 and 144:
APPENDICES141 Appendix 2 Patient in
- Page 145 and 146:
APPENDICES143 We determined the opt
- Page 147 and 148:
APPENDICES145 Appendix 5 Detail des
- Page 149 and 150:
APPENDICES147 Appendix 6 Table of c
- Page 151 and 152:
APPENDICES149 Appendix 8 An example
- Page 153:
APPENDICES151 IX
- Page 156 and 157:
154 CHAPTER X List of publications
- Page 158 and 159:
156 CHAPTER X Honors and awards 201
- Page 160 and 161:
158 CHAPTER X Lieve Victor, ‘jouw
- Page 162 and 163:
160 CHAPTER X doet is het mooiste w